Orchid Island Capital, Inc. annual report, FY2012

Orchid Island Capital, Inc. — FY 2012 Form 10-K

Reporting period: Fiscal year ended December 31, 2012; comparisons are with FY 2011. This is an annual filing, not a standalone fourth-quarter report. Orchid invests in Agency residential mortgage-backed securities (RMBS), using both pass-through and structured securities. Before its February 2013 IPO, it was wholly owned by Bimini Capital Management and operated as Bimini’s qualified REIT subsidiary.

Financial results and position

MetricFY 2012FY 2011
Interest income$2.698 million$1.771 million
GAAP net interest income$2.421 million$1.675 million
Net portfolio income, after MBS and futures losses$1.267 million$0.402 million
Operating expenses$0.733 million$1.592 million
Net income (loss)$0.534 million($1.190 million)
Basic and diluted earnings (loss) per share$0.54($1.21)
  • Portfolio and returns: Year-end Agency and government MBS fair value was $115.4 million, versus $56.0 million a year earlier. Average MBS holdings rose to $74.9 million from $37.6 million, while the average portfolio yield declined to 3.60% from 4.71%. The economic net interest spread was 3.10%, down from 3.93% in 2011.
  • Quarterly detail: In Q4 2012, economic net interest income was $378,000 and the economic net interest spread was 1.61%, compared with $625,000 and 3.79% in Q3. The Q4 total portfolio yield was 2.08%; structured MBS interest income was negative $124,000. The filing does not provide a clear standalone Q4 net income figure in the supplied text.
  • Valuation effects: FY 2012 included $308,000 of realized MBS losses, $806,000 of unrealized MBS losses, and $40,000 of Eurodollar futures losses. Total MBS losses were $1.114 million. The company accounts for MBS at fair value, with changes included in earnings.
  • Liquidity and debt: At year-end, cash and cash equivalents were $2.537 million, restricted cash was $449,000, total assets were $118.861 million, repurchase-agreement borrowings were $103.941 million, total liabilities were $104.136 million, and equity was $14.725 million. Repo debt was about 7.1 times equity. Repo funding carried a 0.49% weighted-average borrowing rate, with a 15-day weighted-average remaining maturity and an approximately 5.6% average haircut.
  • Cash flow: Operating activities provided $1.879 million; investing activities used $60.850 million; financing activities provided $59.616 million. Cash increased by $645,000 to $2.537 million. Purchases and sales of MBS were $199.078 million and $129.069 million, respectively; principal repayments were $9.518 million.

Material changes versus FY 2011

  • Orchid moved from a $1.190 million loss to $534,000 of net income. Higher net interest income and sharply lower expenses more than offset continuing portfolio losses.
  • Interest income increased by $927,000 as average MBS holdings expanded, but the portfolio yield fell 111 basis points. Average repo borrowings increased by $33.750 million, while average economic funding cost declined to 0.50% from 0.78%.
  • Expenses fell by $859,000, principally because FY 2011 included approximately $1.1 million of costs for a proposed IPO that was withdrawn due to market conditions. FY 2012 expenses included approximately $335,000 of management fees and allocated expenses.
  • The portfolio grew and shifted toward pass-through MBS: these represented 95.0% of year-end MBS, versus 83.3% in 2011. Fannie Mae securities were 98.14% of the 2012 portfolio; the prior-year portfolio also included Freddie Mac and Ginnie Mae securities.
  • Effective portfolio duration changed from negative 0.931 at year-end 2011 to positive 1.209 at year-end 2012, indicating greater modeled exposure to rising rates. Management’s sensitivity analysis estimated a 1.21% portfolio value decline for a 100-basis-point rate increase before convexity adjustments; its convexity-adjusted estimate was a 1.96% decline.

Outlook, risks, and notable items

  • Management’s stated strategy is to pursue risk-adjusted returns through leveraged pass-through Agency RMBS and generally unleveraged structured securities, targeting a combined portfolio duration near zero. It expects to continue relying primarily on short-term repurchase agreements. No specific earnings or dividend guidance is provided.
  • Management described liquidity and capital resources as sufficient for investment, debt repayment, and distributions required for REIT qualification. It also reported no material capital-expenditure commitments and no off-balance-sheet arrangements at year-end. These are management assessments, not guarantees.
  • Management highlighted low interest rates, Federal Reserve purchases under QE3, and refinancing programs as potential drivers of higher prepayments and reduced net interest margins. Rising rates could increase repo costs faster than asset income adjusts; lower MBS prices could trigger margin calls or constrain funding.
  • Other key risks include short-term refinancing and counterparty exposure, leverage, prepayment and extension risk, fair-value estimation, and uncertainty about the future role and guarantees of Fannie Mae and Freddie Mac. Structured interest-only and inverse interest-only securities carry particularly high prepayment sensitivity.
  • Orchid completed its IPO on February 20, 2013, selling 2.36 million shares at $15.00 for $35.4 million in proceeds; the manager paid the offering costs. Bimini held approximately 29.38% after the offering. Orchid listed on NYSE MKT in February 2013 and declared its first cash dividend, $0.135 per share, in March 2013. It intended to elect REIT status for its short taxable period beginning February 20, 2013.
  • The financial statements received an unqualified audit opinion. Management concluded disclosure controls were effective; the filing did not include management’s internal-control assessment or auditor attestation because of the newly public company transition period.

Key facts investors should verify

  • Whether current repo funding, borrowing costs, haircuts, collateral requirements, and counterparty concentration have changed materially since year-end 2012.
  • How subsequent portfolio growth and asset allocation affected leverage, duration, fair value, and sensitivity to interest rates and prepayments.
  • Whether actual prepayment speeds and net interest margins align with management’s assumptions, especially for IO and IIO securities.
  • Whether post-IPO earnings and cash generation support the declared monthly distribution; the filing states there is no minimum distribution guarantee.
  • Whether Orchid satisfied the requirements for its intended REIT election and continued to qualify for its Investment Company Act exemption.
  • The filing gives two slightly different March 2013 outstanding-share counts: 3,341,665 on the cover and 3,341,655 in the market-information section. Investors should confirm the correct figure.